In vivo tracking of unlabelled mesenchymal stromal cells by mannose-weighted chemical exchange saturation transfer MRI

High-mannose N-linked glycans, which are abundantly expressed on the surface of human mesenchymal stromal cells, can serve as a biomarker for the in vivo tracking of the cells via chemical exchange saturation transfer magnetic resonance imaging. The tracking of the in vivo biodistribution of transplanted human mesenchymal stromal cells (hMSCs) relies on reporter genes or on the addition of exogenous imaging agents. However, reporter genes and exogenous labels may require bespoke manufacturing and regulatory processes if used in cell therapies, and the labels may alter the cells' properties and are diluted on cellular division. Here we show that high-mannose N-linked glycans, which are abundantly expressed on the surface of hMSCs, can serve as a biomarker for the label-free tracking of transplanted hMSCs by mannose-weighted chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI). For live mice with luciferase-transfected hMSCs transplanted into their brains, post-mortem fluorescence staining with a mannose-specific lectin showed that increases in the CEST MRI signal, which correlated well with the bioluminescence intensity of viable hMSCs for 14 days, corresponded to the presence of mannose. In vitro, osteogenically differentiated hMSCs led to lower CEST MRI signal intensities owing to the concomitantly reduced expression of mannose. The label-free imaging of hMSCs may facilitate the development and testing of cell therapies.

Automated summary

This study demonstrates that high-mannose N-linked glycans can serve as a biomarker for label-free tracking of transplanted human mesenchymal stromal cells (hMSCs) using mannose-weighted chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI). This label-free imaging method may facilitate the development and testing of cell therapies.